Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Mannino
Emory University, Department: Pediatrics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sanguina, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The COI Committee reviewed Dr. Mannino’s role on the R21, his interests in the technology being studied therein, his equity interest in Sanguina, his interest in the commercial hemoglobin self-monitoring technology that Sanguina jointly owns with Emory and Georgia Tech Research Corporation, and how that technology relates to his work on the R21. The Committee determined that he has a Financial Conflict of Interest (FCOI) on this project because he is an inventor of the technology being evaluated and he holds equity in a company that is commercializing a technology closely related to the technology being developed in the R21.
Non-invasive quantitative hemoglobin self-monitoring using only smartphone images for chronic anemia patients
Project Narrative Sickle cell disease (SCD) is a genetic blood disorder that is characterized by chronic anemia and frequent episodes of acute pain, which can be associated with concurrent worsening of the anemia. We have recently developed an inexpensive, disposable, patient-operated, color-based, diagnostic that could enable pediatric SCD patients to objectively self-monitor their anemia. The goal of this study is to evaluate the feasibility of our anemia self-test as a means to enable and improve disease self-management for pediatric and adolescent patients with SCD.
Filed on January 14, 2019.
Tell us what you know about Robert Mannino's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Robert Mannino”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert Mannino | Georgia Institute of Technology | Conflict of Interest | Sanguina, LLC |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.